Literature DB >> 24840340

Asymmetric dimethylarginine and whole blood viscosity in renal failure.

Mary S Hammes1, Sydeaka Watson2, Frederic L Coe1, Faris Ahmed1, Emily Beltran3, Promila Dhar3.   

Abstract

BACKGROUND: Renal failure is a disease with accelerated atherosclerosis beginning with endothelial cell dysfunction. Factors affecting endothelial cell dysfunction include whole blood viscosity (WBV) and asymmetric dimethylarginine (ADMA). The relationship in controls and renal failure was determined.
METHODS: 51 subjects, 20 controls, 11 renal transplant recipients, 10 chronic kidney disease and 10 end-stage renal disease patients had blood samples drawn for WBV, Hematocrit, and ADMA. WBV was measured at various shear rates from 10 s(-1) to 780 s(-1) at 37 °C. Hematocrit using CritSpin, and ADMA was assayed using an ELISA method. The significance between groups was compared by boxplots and analysis of variance. Linear relationships were shown by regression lines and correlation coefficients.
RESULTS: ADMA was elevated in all groups with renal failure when compared to controls (p < 0.05). Control subjects showed a positive correlation between ADMA and WBV, while those who received a renal transplant had a negative correlation (p < 0.05). The difference in ADMA comparing pre-dialysis to post-dialysis conditions was positive (p < 0.05).
CONCLUSIONS: The positive relationship between WBV and ADMA in controls is a novel finding and allows for comparison with other groups. This relationship is dramatically altered in renal failure.

Entities:  

Keywords:  Asymmetric dimethylarginine; endothelial cell; nitric oxide; renal failure; viscosity

Mesh:

Substances:

Year:  2015        PMID: 24840340      PMCID: PMC4408200          DOI: 10.3233/CH-141843

Source DB:  PubMed          Journal:  Clin Hemorheol Microcirc        ISSN: 1386-0291            Impact factor:   2.375


  27 in total

1.  Asymmetric dimethylarginine in hemodialysis, hemodiafiltration, and peritoneal dialysis.

Authors:  Jaromír Eiselt; Daniel Rajdl; Jaroslav Racek; Romana Siroká; Ladislav Trefil; Sylvie Opatrná
Journal:  Artif Organs       Date:  2010-05       Impact factor: 3.094

2.  Protecting the endothelium: a new focus for management of chronic kidney disease.

Authors:  Jose A Diaz-Buxo; H Feidhlim Woods
Journal:  Hemodial Int       Date:  2006-01       Impact factor: 1.812

3.  Endothelial functions improve with decrease in asymmetric dimethylarginine (ADMA) levels after renal transplantation.

Authors:  Mahmut Ilker Yilmaz; Mutlu Saglam; Kayser Caglar; Erdinc Cakir; Taner Ozgurtas; Alper Sonmez; Tayfun Eyileten; Mujdat Yenicesu; Cengizhan Acikel; Yusuf Oguz; Omer Ozcan; Ugur Bozlar; Kemal Erbil; Ismail Aslan; Abdulgaffar Vural
Journal:  Transplantation       Date:  2005-12-27       Impact factor: 4.939

4.  Concentration of dimethyl-L-arginine in the plasma of patients with end-stage renal failure.

Authors:  R J MacAllister; M H Rambausek; P Vallance; D Williams; K H Hoffmann; E Ritz
Journal:  Nephrol Dial Transplant       Date:  1996-12       Impact factor: 5.992

5.  Nitric oxide generation in red blood cells induced by mechanical stress.

Authors:  Pinar Ulker; Herbert J Meiselman; Oguz K Baskurt
Journal:  Clin Hemorheol Microcirc       Date:  2010       Impact factor: 2.375

6.  Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study.

Authors:  C Zoccali; S Bode-Böger; F Mallamaci; F Benedetto; G Tripepi; L Malatino; A Cataliotti; I Bellanuova; I Fermo; J Frölich; R Böger
Journal:  Lancet       Date:  2001 Dec 22-29       Impact factor: 79.321

7.  Whole blood viscosity: Effect of hemodialysis treatment and implications for access patency and vascular disease.

Authors:  Promila Dhar; Michael Eadon; Patrick Hallak; Ramon Augustine Munoz; Mary Hammes
Journal:  Clin Hemorheol Microcirc       Date:  2012       Impact factor: 2.375

Review 8.  Nitric oxide deficiency in chronic kidney disease.

Authors:  Chris Baylis
Journal:  Am J Physiol Renal Physiol       Date:  2007-10-10

9.  Asymmetrical dimethylarginine is associated with renal and cardiovascular outcomes and all-cause mortality in renal transplant recipients.

Authors:  Sadollah Abedini; Andreas Meinitzer; Ingar Holme; Winfried März; Gisela Weihrauch; Bengt Fellstrøm; Alan Jardine; Hallvard Holdaas
Journal:  Kidney Int       Date:  2010-01       Impact factor: 10.612

10.  Role of the kidneys in resistant hypertension.

Authors:  Z Khawaja; C S Wilcox
Journal:  Int J Hypertens       Date:  2011-03-14       Impact factor: 2.420

View more
  3 in total

Review 1.  Hemodynamic and biologic determinates of arteriovenous fistula outcomes in renal failure patients.

Authors:  Mary Hammes
Journal:  Biomed Res Int       Date:  2015-10-01       Impact factor: 3.411

2.  Longxuetongluo Capsule Improves Erythrocyte Function against Lipid Peroxidation and Abnormal Hemorheological Parameters in High Fat Diet-Induced ApoE-/- Mice.

Authors:  Jiao Zheng; Binglin Liu; Qixing Lun; Weijuan Yao; Yunfang Zhao; Wei Xiao; Wenzhe Huang; Yonghua Wang; Jun Li; Pengfei Tu
Journal:  Oxid Med Cell Longev       Date:  2015-11-16       Impact factor: 6.543

3.  Asymmetric Dimethylarginine does not Predict Early Access Events in Hemodialysis Patients with Brachiocephalic Fistula Access.

Authors:  Mary Hammes; Rita McGill; Promila Dhar; Rama S Madhurapantula
Journal:  Int J Nephrol Kidney Fail       Date:  2017-04-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.